BC Platforms to Enable Longitudinal RWD and Genomics Access for Drug Development in Africa
13 Sept 2021 – Zurich, Switzerland and Johannesburg, South Africa – Today, BC Platforms (BCP), a global leader in genomics research, analytics and global data access, announced a new collaboration with the African Institute of Everyone Genome (AiEG), a South African genomic company focusing on building the largest integrated clinical and genomics data biobank in the African continent. As part of the collaboration, BCP’s platform will enable RWD research involving 10M+ consenting patient genomes from all 54 African countries, to be collected by AiEG over a period of 10-15 years. The main goal of the research will be to enable drug development and clinical research for patients in sub-Saharan Africa.
